Literature DB >> 18472965

Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles.

Ilaria Giusti1, Sandra D'Ascenzo, Danilo Millimaggi, Giulia Taraboletti, Gaspare Carta, Nicola Franceschini, Antonio Pavan, Vincenza Dolo.   

Abstract

Vesicles shed by cancer cells are known to mediate several tumor-host interactions. Tumor microenvironment may, in turn, influence the release and the activity of tumor-shed microvesicles. In this study, we investigated the molecular mediators of the pH-dependent proinvasive activity of tumor-shed vesicles. Gelatinase zymography showed increased microvesicle activity of matrix metalloproteinases 9 and 2 as a result of acid exposure (pH 5.6) compared to pH 7.4. Thus, we reasoned that the cysteine protease cathepsin B might play a role in mediating the pH-dependent activation of gelatinases. Cathepsin B expression in tumor-shed microvesicles was confirmed by Western blot analysis and zymography. The activity of vesicle-associated cathepsin B measured using Z-Arg-Arg-pNA as substrate was significantly increased at acidic pH values. Inhibition of protease activity by the cysteine protease inhibitor, E-64, and treatment of ovarian cancer cells with small interfering RNA against cathepsin B suppressed the ability of tumor-shed microvesicles to stimulate both gelatinase activation and the invasiveness of endothelial cells observed at low pH values. We conclude that microvesicle shedding is a major secretory pathway for cathepsin B release from tumor cells. Hence, the acidic microenvironment found in most solid tumors may contribute to cathepsin B-mediated proinvasive capabilities of tumor-shed vesicles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18472965      PMCID: PMC2373913          DOI: 10.1593/neo.08178

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  44 in total

1.  Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells.

Authors:  Giulia Taraboletti; Sandra D'Ascenzo; Patrizia Borsotti; Raffaella Giavazzi; Antonio Pavan; Vincenza Dolo
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

2.  CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells.

Authors:  Metwally Montaser; Gilles Lalmanach; Lukas Mach
Journal:  Biol Chem       Date:  2002 Jul-Aug       Impact factor: 3.915

3.  Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells.

Authors:  Q Shi; X Le; B Wang; J L Abbruzzese; Q Xiong; Y He; K Xie
Journal:  Oncogene       Date:  2001-06-21       Impact factor: 9.867

4.  Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin.

Authors:  Chan Woo Kim; Hwan Myung Lee; Tae Hoon Lee; Chulhun Kang; Hynda K Kleinman; Yong Song Gho
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

Review 5.  Tumor-derived exosomes: a new source of tumor rejection antigens.

Authors:  F André; N E C Schartz; N Chaput; C Flament; G Raposo; S Amigorena; E Angevin; L Zitvogel
Journal:  Vaccine       Date:  2002-12-19       Impact factor: 3.641

6.  Plasma membrane association of cathepsin B in human prostate cancer: biochemical and immunogold electron microscopic analysis.

Authors:  A A Sinha; M P Jamuar; M J Wilson; J Rozhin; B F Sloane
Journal:  Prostate       Date:  2001-11-01       Impact factor: 4.104

7.  Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.

Authors:  Jianxin Mai; Mansoureh Sameni; Tom Mikkelsen; Bonnie F Sloane
Journal:  Biol Chem       Date:  2002-09       Impact factor: 3.915

8.  Imaging proteolysis by living human breast cancer cells.

Authors:  M Sameni; K Moin; B F Sloane
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

Review 9.  Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease.

Authors:  D P Dickinson
Journal:  Crit Rev Oral Biol Med       Date:  2002

Review 10.  The evolving concept of tumor microenvironments.

Authors:  Ezio Laconi
Journal:  Bioessays       Date:  2007-08       Impact factor: 4.345

View more
  58 in total

Review 1.  Dysregulated pH: a perfect storm for cancer progression.

Authors:  Bradley A Webb; Michael Chimenti; Matthew P Jacobson; Diane L Barber
Journal:  Nat Rev Cancer       Date:  2011-08-11       Impact factor: 60.716

2.  Microencapsulation technology by nature: Cell derived extracellular vesicles with therapeutic potential.

Authors:  A Kittel; A Falus; E Buzás
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-06-05

Review 3.  Tumor-derived extracellular vesicles: molecular parcels that enable regulation of the immune response in cancer.

Authors:  Colin Sheehan; Crislyn D'Souza-Schorey
Journal:  J Cell Sci       Date:  2019-10-15       Impact factor: 5.285

4.  Acid-mediated tumor proteolysis: contribution of cysteine cathepsins.

Authors:  Jennifer M Rothberg; Kate M Bailey; Jonathan W Wojtkowiak; Yael Ben-Nun; Matthew Bogyo; Ekkehard Weber; Kamiar Moin; Galia Blum; Raymond R Mattingly; Robert J Gillies; Bonnie F Sloane
Journal:  Neoplasia       Date:  2013-10       Impact factor: 5.715

Review 5.  Microvesicles: mediators of extracellular communication during cancer progression.

Authors:  Vandhana Muralidharan-Chari; James W Clancy; Alanna Sedgwick; Crislyn D'Souza-Schorey
Journal:  J Cell Sci       Date:  2010-05-15       Impact factor: 5.285

6.  Long non-coding RNA HOTAIR enhances angiogenesis by induction of VEGFA expression in glioma cells and transmission to endothelial cells via glioma cell derived-extracellular vesicles.

Authors:  Xin Ma; Zhaohui Li; Ting Li; Linwensi Zhu; Zhenshengnan Li; Nan Tian
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

7.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

Review 8.  Cell-to-cell miRNA transfer: from body homeostasis to therapy.

Authors:  Roxana S Redis; Steliana Calin; Yaling Yang; M James You; George A Calin
Journal:  Pharmacol Ther       Date:  2012-08-08       Impact factor: 12.310

9.  From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis.

Authors:  Ilaria Giusti; Simona Delle Monache; Marianna Di Francesco; Patrizia Sanità; Sandra D'Ascenzo; Giovanni Luca Gravina; Claudio Festuccia; Vincenza Dolo
Journal:  Tumour Biol       Date:  2016-07-22

10.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.